These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6442174)

  • 1. [Experimental studies in vitro on the antituberculous activities of 27753RP (R.P), a semisynthetic derivative of griselimycine. III. Cross resistance of R.P].
    Shibata A
    Bull Chest Dis Res Inst Kyoto Univ; 1984 Mar; 17(1-2):38-42. PubMed ID: 6442174
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental studies in vitro on the antituberculous activities of 27753 (R.P), a semisynthetic derivative of griselimycine. II. Antituberculous activities of R.P. in combination with other antituberculous agents].
    Shibata A
    Bull Chest Dis Res Inst Kyoto Univ; 1984 Mar; 17(1-2):32-7. PubMed ID: 6442173
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental studies in vitro on the antituberculous activities of 27753RP (R.P), a semisynthetic derivative of griselimycine. I. Antituberculous activities of R.P examined at intermittent, short time and continuous exposure in vitro].
    Shibata A
    Bull Chest Dis Res Inst Kyoto Univ; 1984 Mar; 17(1-2):26-31. PubMed ID: 6442172
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental studies in vitro on the antituberculous activities of 27753RP (R.P), a semisynthetic derivative of griselimycine. IV. Antituberculous activities of R.P in vitro under various inadequate conditions for the growth of tubercle bacilli].
    Shibata A
    Bull Chest Dis Res Inst Kyoto Univ; 1984 Mar; 17(1-2):43-9. PubMed ID: 6442175
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental study on the antituberculous activity of 27753R. P., a semisynthetic derivative of griselimycine (author's transl)].
    Toyohara M
    Kekkaku; 1980 Nov; 55(11):473-9. PubMed ID: 7463925
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antituberculous action of a new antibiotic, Lividomycin. Effect on experimental tuberculosis of mice and cross resistance with other antituberculous agents].
    Tsukamura M; Mizuno S; Yamamoto M
    Kekkaku; 1970 Aug; 45(8):263-72. PubMed ID: 4989999
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM and TUM. I. The sensitivity of human tubercle bacilli isolated from patients to the five antibiotics (author's transl)].
    Saito T; Fukuhara Y
    Kekkaku; 1974 Mar; 49(3):57-61. PubMed ID: 4136031
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on antituberculous activity of lividomycin in vitro].
    Horai Z; Shimizu K; Yamamoto K; Fujisawa Y; Yamashita K
    Kekkaku; 1971 Oct; 46(10):401-4. PubMed ID: 5004573
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
    Gol'shevskaia VI; Grishina TA; Karpenko OL; Safonova SG; Grishina TD
    Probl Tuberk; 1995; (4):37-40. PubMed ID: 7567869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The study of the in vitro antituberculous activity of capreomycin].
    Ravagnan L; Renzini G
    Antibiotica; 1968 Sep; 6(3):152-61. PubMed ID: 4983488
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug resistance of Mycobacterium tuberculosis and its significance in the hospital practice].
    Rudoĭ NM
    Probl Tuberk; 1996; (3):6-8. PubMed ID: 8754863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of primary resistance to antitubercular agents in the Sousse region, 1981-1990].
    Benzarti M; Garrouche A; Jerray M; Hayouni A; Maalel K; Klabi N
    Tunis Med; 1996 Jan; 74(1):23-7. PubMed ID: 9507309
    [No Abstract]   [Full Text] [Related]  

  • 13. [Primary resistance of Mycobacterium tuberculosis in the province of Vizcaya].
    Echeverría MJ; Ayarza R; Jiménez MS; López de Goicoechea MJ; Berdonces P; Ibarretxebea AB
    Rev Esp Quimioter; 1999 Jun; 12(2):152-3. PubMed ID: 10562678
    [No Abstract]   [Full Text] [Related]  

  • 14. The fundamental studies on antituberculous activities of lividomycin.
    Gomi J; Aoyagi T; Torikai K; Yamada Y; Fujino T
    Kekkaku; 1971 Jul; 46(7):265-9. PubMed ID: 4329783
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the sensitivity to TUM-N of tubercle bacilli isolated from tuberculous patients who had never employed TUM-N--for determination of the critical concentration of TUM-N resistance (author's transl)].
    Toyoara M
    Kekkaku; 1973 Sep; 48(9):405-10. PubMed ID: 4203986
    [No Abstract]   [Full Text] [Related]  

  • 16. Validation of a rapid method for detection of M. tuberculosis resistance to INH and RMP in Lima, Peru.
    De Kantor IN
    Int J Tuberc Lung Dis; 2006 Jun; 10(6):707; author reply 707-8. PubMed ID: 16776461
    [No Abstract]   [Full Text] [Related]  

  • 17. [The experimental studies on antituberculous activity of lividomycin].
    Yamamoto K; Sakurai H; Inoue I; Yamagami K
    Kekkaku; 1972 May; 47(5):135-8. PubMed ID: 4339540
    [No Abstract]   [Full Text] [Related]  

  • 18. [The mutual cross-resistance of aminoglucoside and polypeptide antibiotics on tubercle bacilli (author's transl)].
    Inagake H
    Kekkaku; 1980 Jun; 55(6):281-8. PubMed ID: 6774157
    [No Abstract]   [Full Text] [Related]  

  • 19. [In vitro effects of several kinds of gas exposure on the antimicrobial activities of antituberculous agents. Chapter III. The development of drug resistance (author's transl)].
    Yamadori H
    Kekkaku; 1981 Nov; 56(11):521-4. PubMed ID: 6799686
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug resistance in tuberculosis.
    Ebrahim GJ
    J Trop Pediatr; 2007 Jun; 53(3):147-9. PubMed ID: 17526511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.